Research
At Vaccelix Biopharma, our research initiatives are rooted in innovation, scientific rigor, and a passion for delivering life-changing therapies. We are advancing the frontiers of science to improve patient outcomes globally.
Discovery Research
Exploring Novel Therapies
Our discovery teams focus on target validation, lead identification, and optimizing drug candidates across oncology, immunology, and rare diseases.
- High-Throughput Screening
- Target Identification
- Early-stage Pipeline
Bioconjugation & ADCs
Precision Therapeutics
We specialize in Antibody-Drug Conjugates (ADCs), combining potent cytotoxins with monoclonal antibodies to create targeted cancer therapies.
- Linker-Drug Optimization
- Site-Specific Conjugation
- cGMP ADC Manufacturing
Clinical Trials
Translating Science to Medicine
Our clinical research unit executes Phases I–IV trials across therapeutic areas, with strong regulatory, pharmacovigilance, and bioethics frameworks in place.
Process Development
Scalable & Reliable Production
We optimize upstream and downstream processes to ensure consistent production of biologics and complex molecules under cGMP conditions.
- Cell Line Development
- Purification Protocols
- Tech Transfer
Bioanalytics
Data-Driven Precision
Our labs conduct pharmacokinetic, immunogenicity, and biomarker analysis to support development and regulatory submissions.
- ELISA & LC-MS/MS
- Stability Studies
- Biomarker Discovery